about
Surgery for combined type small cell lung carcinomaSmall-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of LiteratureTransformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originCombined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components.Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases.Mutation status of epidermal growth factor receptor and clinical features of patients with combined small cell lung cancer who received surgical treatment.Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer.Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.Further understanding of an uncommon disease of combined small cell lung cancer: clinical features and prognostic factors of 114 cases.Clinical outcomes of surgically resected combined small cell lung cancer: a two-institutional experience.Small cell lung cancer transformation during immunotherapy with nivolumab: A case report.Elevated RABEX-5 protein expression predicts poor prognosis in combined small cell lung cancer.Metformin use improves the survival of diabetic combined small-cell lung cancer patients.Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report.Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC).Unusual presentation of an uncommon lung malignancyHuman epididymis protein 4 may not be a reliable screening biomarker for detecting lung carcinoma patients.Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors.[Advances in the Transformation to Small Cell Lung Cancer from Non-small Cell Lung Cancer Following Acquired Drug-resistance to EGFR Tyrosine Kinase Inhibitors].High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer.EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients.Combined small-cell lung carcinoma.[Clinical analysis of 80 patients with combined small-cell lung cancer].
P2860
Q24679475-E25F05EA-AAEB-48CA-A4C1-86908A273B27Q26766283-292BAE76-F58D-463F-BA70-E135BCEA8367Q26826437-065A7951-C49E-4D86-94FC-6ACAB29E1BDDQ34948434-F57930AB-C1F4-44A3-BFF2-11BBE9173085Q35824126-C42393FA-760A-4249-8B0D-862AD4A16CCBQ36084381-BFC4210C-6522-4C5D-8F2F-F5A320692A83Q36099315-71B676AD-3FB3-404B-83E2-5B25A4B919AEQ37376246-6EAE6634-9163-4712-8CE1-8DA26464EF05Q37402093-8D40BD57-5D78-48AF-98DB-48B392C5BA30Q37636909-6633B7F3-BBE6-4250-895B-C8BC0703EA26Q37733355-64F29D61-DBAF-4086-9DA1-4B3FF4DFCEDEQ40909548-9C570EF6-A064-4FDF-A95E-5BB594FF6172Q40930334-F4E73F2E-2410-4244-BE39-2071069F9352Q40979412-9F560850-1F8F-4D2B-92D7-94053D4763A8Q41016802-BE773422-BA29-4DC0-A879-949EF8635F00Q41472199-AEE9D13A-C733-45C3-94B1-0A5ED060CB69Q42740334-122B4E0C-4CCD-4033-906B-D03B694262CFQ47120251-E421343D-57E2-4A32-85ED-B428818D2DBCQ48354758-100CF476-3085-49C8-A776-0B368978FB1AQ50072136-B269B675-6DF2-4202-9F31-E05C8E8B57F9Q51626805-A31DD814-4561-45EF-ABA7-BD5362B0C043Q54222458-2EE48D15-1C2F-4BB0-877D-26AE964F7CB1Q55332272-41376966-68C9-44CD-A031-A37D86FF3AAFQ55425585-0EECE1AC-C8F8-4F4B-BC92-F737A3546FD6
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Combined small-cell and non-small-cell lung cancer.
@ast
Combined small-cell and non-small-cell lung cancer.
@en
Combined small-cell and non-small-cell lung cancer.
@nl
type
label
Combined small-cell and non-small-cell lung cancer.
@ast
Combined small-cell and non-small-cell lung cancer.
@en
Combined small-cell and non-small-cell lung cancer.
@nl
prefLabel
Combined small-cell and non-small-cell lung cancer.
@ast
Combined small-cell and non-small-cell lung cancer.
@en
Combined small-cell and non-small-cell lung cancer.
@nl
P2093
P356
P1476
Combined small-cell and non-small-cell lung cancer.
@en
P2093
D H Johnson
J D Hainsworth
M D Mangum
P304
P356
10.1200/JCO.1989.7.5.607
P407
P577
1989-05-01T00:00:00Z